Andrew S. Brohl

Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors

Jack F. Shern, Li Chen, Juliann Chmielecki et al. · Cancer Discovery · 2014 · 777 citations · Full text

Medicine, Molecular Genetics, Oncology +17

The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation

Andrew S. Brohl, David A. Solomon, Wendy Chang et al. · PLoS Genetics · 2014 · 453 citations · Full text

Medicine, Genetics, Oncology +17

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma

Megan H. Pollack, Helen Clare Dearden, K. Rapazzo et al. · Annals of Oncology · 2017 · 392 citations · Full text

Pharmacy, Immunology, Oncology +14

Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · Journal of Clinical Oncology · 2019 · 390 citations · Full text

Medicine, Oncology, Pharmacology +17

Monogenic and polygenic determinants of sarcoma risk: an international genetic study

Mandy L. Ballinger, David L. Goode, Isabelle Ray‐Coquard et al. · The Lancet Oncology · 2016 · 213 citations

Life Sciences, Genetics, Oncology +16